MedPath

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy Without Prior Spontaneous Preterm Birth

Phase 3
Withdrawn
Conditions
Preterm Birth
Interventions
Other: TVU CL screening
Registration Number
NCT02928302
Lead Sponsor
Federico II University
Brief Summary

Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.

However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, we aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy without prior spontaneous PTB

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • 18-50 years of age
  • Singleton pregnancy (limits the participants to female gender)
  • No prior spontaneous preterm delivery, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks
Exclusion Criteria
  • Multiple gestation
  • Prior spontaneous preterm birth 16-36 6/7 weeks
  • Ruptured membranes at time of randomization
  • Lethal fetal structural anomaly at time of randomization
  • Fetal chromosomal abnormality at time of randomization
  • Placenta previa and/or accreta at time of randomization
  • Women who already underwent TVU CL measurement during the index pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TVU CL screeningTVU CL screeningTVU CL screening: single TVU CL at 18 0/7 to 23 6/7 every week
Primary Outcome Measures
NameTimeMethod
preterm birth rateLess than 37 weeks

either spontaneous or indicated preterm delivery

Secondary Outcome Measures
NameTimeMethod
Neonatal deathBetween birth and 28 days of age
necrotizing enterocolitisBetween birth and 28 days of age

Defined as modified Bell Stage 2 or 3. Stage 2: Clinical signs and symptoms with pneumatosis intestinalis on radiographs. Stage 3: Advanced clinical signs and symptoms, pneumatosis, impending or proven intestinal perforation

Perinatal deathBetween birth and 28 days of age

either neonatal death or fetal death

gestational age at deliverytime of delivery
latencytime of delivery

from randomization to delivery

admission to neonatal intensive care unittime of delivery
intraventricular hemorrhage (grade 3 or higher)Between birth and 28 days of age

IVH

preterm birth ratesLess than 24, 28, 32, 30, and 34 weeks gestation

either spontaneous or indicated preterm delivery

Composite perinatal outcomeBetween birth and 28 days of age

Includes necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death

Length of hospital stayDischarge from hospital

Days in NICU

respiratory distress syndromeTime of delivery

Respiratory distress with an oxygen requirement and a chest x-ray that shows hypoaeration and reticulogranular infiltrates

birth weighttime of delivery

Trial Locations

Locations (1)

Gabriele Saccone

🇮🇹

Naples, Italy

© Copyright 2025. All Rights Reserved by MedPath